The estimated Net Worth of Yuichi Iwaki is at least $5.58 Millón dollars as of 25 February 2021. Yuichi Iwaki owns over 86,250 units of Medicinova Inc stock worth over $1,817,606 and over the last 18 years he sold MNOV stock worth over $0. In addition, he makes $3,761,890 as President, Chief Executive Officer y Director at Medicinova Inc.
Sign up
Yuichi Iwaki MNOV stock SEC Form 4 insiders trading
Yuichi has made over 13 trades of the Medicinova Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 86,250 units of MNOV stock worth $212,175 on 25 February 2021.
The largest trade he's ever made was exercising 86,250 units of Medicinova Inc stock on 25 February 2021 worth over $212,175. On average, Yuichi trades about 10,176 units every 148 days since 2007. As of 25 February 2021 he still owns at least 927,350 units of Medicinova Inc stock.
You can see the complete history of Yuichi Iwaki stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Yuichi Iwaki biography
Dr. Yuichi Iwaki M.D. Ph.D. serves as President, Chief Executive Officer, Director of the Company. He is a founder of our Company and served as the Chairman of the Board of Directors from our inception in September 2000 to March 2007, becoming Executive Chairman in July 2005, Acting Chief Executive Officer as of September 2005 and President and Chief Executive Officer as of March 2006. From September 2001 until January 2007, Dr. Iwaki also served as our consultant in connection with financing transactions and business development activities. Dr. Iwaki was a member of the board of directors of Avigen, Inc. from 1994 to 2008. He holds three professorships at the University of Southern California School of Medicine in the Departments of Urology, Surgery and Pathology and has been Director of the Transplantation Immunology and Immunogenetic Laboratory since 1992. Dr. Iwaki is also a visiting professor at the Toho University School of Medicine. Prior to joining the faculty at the University of Southern California School of Medicine, Dr. Iwaki held two professorships at the University of Pittsburgh School of Medicine in the Departments of Surgery and Pathology from 1989 through 1991. Dr. Iwaki received both his M.D. and Ph.D. degrees from Sapporo Medical School in Sapporo, Japan. Dr. Iwaki is the author of more than 200 peer-reviewed publications and more than 40 book chapters. Dr. Iwaki has been advising pharmaceutical companies and venture capital funds regarding research and investment strategies for over 30 years and serves on the board of directors of several biotechnology companies.
What is the salary of Yuichi Iwaki?
As the President, Chief Executive Officer y Director of Medicinova Inc, the total compensation of Yuichi Iwaki at Medicinova Inc is $3,761,890. There are no executives at Medicinova Inc getting paid more.
How old is Yuichi Iwaki?
Yuichi Iwaki is 70, he's been the President, Chief Executive Officer y Director of Medicinova Inc since 2020. There are 1 older and 9 younger executives at Medicinova Inc. The oldest executive at Medicinova Inc is Dr. Yuichi Iwaki M.D., Ph.D., 71, who is the Co-Founder, Pres, CEO & Exec. Director.
What's Yuichi Iwaki's mailing address?
Yuichi's mailing address filed with the SEC is C/O MEDICINOVA, INC., 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037.
Insiders trading at Medicinova Inc
Over the last 18 years, insiders at Medicinova Inc have traded over $200,908 worth of Medicinova Inc stock and bought 459,744 units worth $1,581,779 . The most active insiders traders include Jeff Himawan, Masatsune Okajima y Yuichi Iwaki. On average, Medicinova Inc executives and independent directors trade stock every 95 days with the average trade being worth of $74,094. The most recent stock trade was executed by Hideki Nagao on 28 November 2022, trading 6,754 units of MNOV stock currently worth $15,197.
What does Medicinova Inc's logo look like?
Complete history of Yuichi Iwaki stock trades at Medicinova Inc
Medicinova Inc executives and stock owners
Medicinova Inc executives and other stock owners filed with the SEC include:
-
Yuichi Iwaki,
President, Chief Executive Officer, Director -
Kazuko Matsuda,
Chief Medical Officer, Director -
Geoffrey O'brien,
Vice President -
Dr. Yuichi Iwaki M.D., Ph.D.,
Co-Founder, Pres, CEO & Exec. Director -
Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.,
Chief Medical Officer & Director -
Hideki Nagao,
Independent Director -
Carolyn Beaver,
Director -
Edward Stepanow,
Chief Financial Officer -
Jeffrey Himawan,
Independent Chairman of the Board -
John O'Neil CPA,
Controller -
Dr. David H. Crean Ph.D.,
Chief Bus. Officer -
Dr. Federico Gaeta Ph.D.,
Chief Scientific Officer -
Douglas G Paulin CPA, CPA,
Chief Financial Officer -
Yutaka Kobayashi,
Director -
Yoshio Ishizaka,
Director -
Masatsune Okajima,
VP and Head of Japanese Office -
Federico C.A. Gaeta,
Chief Scientific Officer -
Tatsuo Izumi,
Director -
Den Boom Esther Van,
Chief Financial Officer -
Jeff Himawan,
Director -
John K A Prendergast,
Director -
Hiroaki Shigeta,
Director -
Kirk William Johnson,
Chief Scientific Officer -
Arlene Morris,
Director -
Michael Denis Coffee,
Chief Business Officer -
David D O'toole,
Director -
Alan W Dunton,
Director -
Shintaro Asako,
VP and Chief Financial Officer -
Richard E Sr Gammans,
Chief Development Officer -
Daniel Vapnek,
Director -
Kenneth W Locke,
Chief Scientific Officer -
Michael E Kalafer,
Chief Medical Officer -
Nicole Lemerond,
Director